MiNK Therapeutics, Inc. (INKT) Debt Components
- 2025-12-31: Debt Instrument, Face AmountUSD $5.00M; Convertible Notes Payable, CurrentUSD (m).
- 2025-09-30: Debt Instrument, Face AmountUSD $5.00M; Convertible Notes Payable, CurrentUSD (m).
- 2025-06-30: Debt Instrument, Face AmountUSD $5.00M; Convertible Notes Payable, CurrentUSD (m).
- 2025-03-31: Debt Instrument, Face AmountUSD $5.00M; Convertible Notes Payable, CurrentUSD (m).
MiNK Therapeutics, Inc. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Debt Instrument, Face Amount USD | Convertible Notes Payable, Current USD |
|---|---|---|
| 2025-12-31 | $5.00M | (m) |
| 2025-09-30 | $5.00M | (m) |
| 2025-06-30 | $5.00M | (m) |
| 2025-03-31 | $5.00M | (m) |
| 2024-12-31 | $5.00M | (m) |
| 2024-09-30 | $5.00M | (m) |
| 2024-06-30 | $5.00M | (m) |
| 2024-03-31 | $5.00M | (m) |
| 2021-09-30 | $45.50M | $65.42M |
| 2020-12-31 | $36.10M | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |